• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病患者疲劳的患者报告结局指标:一项系统评价

Patient-reported outcome measures for fatigue in patients with chronic kidney disease: a systematic review.

作者信息

Hughes Anastasia, Ju Angela, Cazzolli Rosanna, Howell Martin, Guha Chandana, Levin Adeera, Manera Karine, Teixeira-Pinto Armando, Torrisi Luca G, Wheeler David C, Wong Germaine, Wu Rebecca, Jaure Allison

机构信息

Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia

Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.

出版信息

BMJ Open. 2025 Jul 16;15(7):e099592. doi: 10.1136/bmjopen-2025-099592.

DOI:10.1136/bmjopen-2025-099592
PMID:40669903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12273140/
Abstract

OBJECTIVE

Fatigue is a common and debilitating symptom that is associated with an increased risk of mortality, dialysis initiation and hospitalisation among patients with chronic kidney disease (CKD). The aim of this study was to identify the characteristics, content and psychometric properties of patient-reported outcome measures (PROMs) used to measure fatigue in patients with CKD not requiring kidney replacement therapy (KRT).

DESIGN

Systematic review. The characteristics, dimensions of fatigue and psychometric properties of these measures were extracted and analysed.

DATA SOURCES

We searched MEDLINE, Embase, PsycINFO and CINAHL from database inception to February 2023.

ELIGIBILITY CRITERIA FOR SELECTING STUDIES

All studies that reported fatigue in patients with CKD stages 1-5 not receiving KRT.

RESULTS

We identified 97 studies (20 (21%) randomised trials, 2 (2%) non-randomised trials and 75 (77%) observational studies). 27 different measures were used to assess fatigue, of which three were author-developed measures. The 36-Item Short Form Health Survey (SF-36) and Kidney Disease Quality of Life - Short Form (KDQOL-SF) were the most frequently used measures (41 (42%) and 24 (25%) studies, respectively). Six (22%) measures were specific to fatigue (Chalder Fatigue Questionnaire, Functional Assessment of Chronic Illness Therapy - Fatigue Scale, Functional Assessment of Cancer Therapy-Fatigue, Fatigue Severity Scale, and author developed Chen & Ku 1998, and Hao 2021) while 21 (78%) included a fatigue subscale or item within a broader construct for example, quality of life. Various content domains assessed included tiredness, ability to think clearly, level of energy, muscle weakness, ability to concentrate, verbal abilities, motivation, memory, negative emotions and life participation. Only two measures (Chronic Kidney Disease Symptom Index - Sri Lanka, Kidney Symptom Questionnaire) were developed specifically for CKD, but they were not specific to fatigue. Six measures (Chronic Kidney Disease Symptom Index - Sri Lanka, Functional Assessment of Cancer Therapy - Anemia, Revised Illness Perception Questionnaire, Kidney Symptom Questionnaire, Short Form 6 Dimension and 36-Item Short Form Health Survey) had been validated in patients with CKD not requiring KRT.

CONCLUSION

PROMs used to assess fatigue in patients with CKD vary in content and few were specific to fatigue in patients with CKD not requiring KRT. Data to support the psychometric robustness of PROMs for fatigue in CKD were sparse. A validated and content-relevant measure to assess fatigue in patients with CKD is needed.

摘要

目的

疲劳是一种常见且使人衰弱的症状,与慢性肾脏病(CKD)患者的死亡风险、开始透析及住院风险增加相关。本研究的目的是确定用于测量非肾脏替代治疗(KRT)的CKD患者疲劳程度的患者报告结局量表(PROMs)的特征、内容及心理测量特性。

设计

系统评价。提取并分析这些量表的特征、疲劳维度及心理测量特性。

数据来源

我们检索了从数据库建立至2023年2月的MEDLINE、Embase、PsycINFO和CINAHL。

选择研究的纳入标准

所有报告1-5期未接受KRT的CKD患者疲劳情况的研究。

结果

我们纳入了97项研究(20项(21%)随机试验、2项(2%)非随机试验和75项(77%)观察性研究)。使用了27种不同的量表来评估疲劳,其中3种是作者自行编制的量表。36项简短健康调查问卷(SF-36)和肾脏病生活质量简表(KDQOL-SF)是最常用的量表(分别有41项(42%)和24项(25%)研究使用)。6种(22%)量表是专门针对疲劳的(查尔德疲劳问卷、慢性病治疗功能评估-疲劳量表、癌症治疗功能评估-疲劳、疲劳严重程度量表,以及作者编制的Chen & Ku 1998年版和Hao 2021年版),而21种(78%)量表在更广泛的结构(如生活质量)中包含疲劳子量表或项目。评估的各种内容领域包括疲倦、清晰思考的能力、精力水平、肌肉无力、集中注意力的能力、语言能力、动力、记忆力、负面情绪和生活参与度。只有两种量表(斯里兰卡慢性肾脏病症状指数、肾脏症状问卷)是专门为CKD编制的,但并非专门针对疲劳。6种量表(斯里兰卡慢性肾脏病症状指数、癌症治疗功能评估-贫血、修订后的疾病认知问卷、肾脏症状问卷、简短健康调查问卷6维度版和36项简短健康调查问卷)在非KRT的CKD患者中得到了验证。

结论

用于评估CKD患者疲劳程度的PROMs在内容上各不相同,很少有专门针对非KRT的CKD患者疲劳情况的量表。支持PROMs对CKD患者疲劳心理测量稳健性的数据很少。需要一种经过验证且与内容相关的量表来评估CKD患者的疲劳情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084e/12273140/be5434d85e01/bmjopen-15-7-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084e/12273140/be5434d85e01/bmjopen-15-7-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084e/12273140/be5434d85e01/bmjopen-15-7-g001.jpg

相似文献

1
Patient-reported outcome measures for fatigue in patients with chronic kidney disease: a systematic review.慢性肾脏病患者疲劳的患者报告结局指标:一项系统评价
BMJ Open. 2025 Jul 16;15(7):e099592. doi: 10.1136/bmjopen-2025-099592.
2
Interventions for chronic kidney disease-associated restless legs syndrome.慢性肾脏病相关不宁腿综合征的干预措施。
Cochrane Database Syst Rev. 2016 Nov 7;11(11):CD010690. doi: 10.1002/14651858.CD010690.pub2.
3
Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review.成年慢性肾脏病患者使用的患者报告结局量表(PROMs)的测量属性:一项系统评价。
PLoS One. 2017 Jun 21;12(6):e0179733. doi: 10.1371/journal.pone.0179733. eCollection 2017.
4
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Acupuncture and related interventions for symptoms of chronic kidney disease.针灸及相关干预措施治疗慢性肾病症状
Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD009440. doi: 10.1002/14651858.CD009440.pub2.
7
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.
8
Home versus in-centre haemodialysis for people with kidney failure.居家透析与中心透析治疗肾衰竭患者的效果比较。
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD009535. doi: 10.1002/14651858.CD009535.pub3.
9
Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes.用于慢性肾病和糖尿病患者的胰高血糖素样肽1(GLP-1)受体激动剂。
Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD015849. doi: 10.1002/14651858.CD015849.pub2.
10
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.

本文引用的文献

1
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.系统评价报告结局测量工具(OMIs)的指南:PRISMA-COSMIN 对 OMIs 的 2024 年修订版。
Health Qual Life Outcomes. 2024 Jul 9;22(1):48. doi: 10.1186/s12955-024-02256-9.
2
Outcomes for clinical trials involving adults with chronic kidney disease: a multinational Delphi survey involving patients, caregivers and health professionals.涉及慢性肾脏病成年患者的临床试验结局:一项涉及患者、照护者和卫生专业人员的多国德尔菲调查。
Nephrol Dial Transplant. 2024 Jul 31;39(8):1310-1321. doi: 10.1093/ndt/gfae010.
3
Content Validity Assessment of the Revised Illness Perception Questionnaire in CKD Using Qualitative Methods.
采用定性方法评估修订版肾脏病患者疾病感知问卷的内容效度。
Int J Environ Res Public Health. 2022 Jul 16;19(14):8654. doi: 10.3390/ijerph19148654.
4
Patient-centred clinical trial design.以患者为中心的临床试验设计。
Nat Rev Nephrol. 2022 Aug;18(8):514-523. doi: 10.1038/s41581-022-00585-w. Epub 2022 Jun 6.
5
The mediating effect of sleep quality and fatigue between depression and renal function in nondialysis chronic kidney disease: a cross-sectional study.非透析慢性肾脏病患者中抑郁与肾功能之间的中介效应:一项横断面研究。
BMC Nephrol. 2022 Mar 31;23(1):126. doi: 10.1186/s12882-022-02757-z.
6
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops.肾小球疾病临床试验的核心结局集:肾脏病标准化结局倡议-肾小球疾病(SONG-GD)利益相关者研讨会报告。
Clin J Am Soc Nephrol. 2022 Jan;17(1):53-64. doi: 10.2215/CJN.07840621. Epub 2021 Dec 30.
7
Patient-led identification and prioritization of exercise interventions for fatigue on dialysis: a workshop report.患者主导的透析疲劳运动干预措施的识别与优先级确定:一份研讨会报告
Clin Kidney J. 2020 Feb 4;14(3):831-839. doi: 10.1093/ckj/sfz200. eCollection 2021 Mar.
8
The development and validation of a revised version of the Medical Outcomes Study Sleep Scale (MOS Sleep-R).医学结局研究睡眠量表修订版(MOS Sleep-R)的开发与验证
J Patient Rep Outcomes. 2021 May 19;5(1):40. doi: 10.1186/s41687-021-00311-3.
9
Systematic review of the use of translated patient-reported outcome measures in cancer trials.癌症试验中翻译后患者报告结局测量的使用的系统评价。
Trials. 2021 Apr 26;22(1):306. doi: 10.1186/s13063-021-05255-z.
10
Fatigue in CKD: Epidemiology, Pathophysiology, and Treatment.慢性肾脏病相关性疲劳:流行病学、病理生理学与治疗。
Clin J Am Soc Nephrol. 2021 Sep;16(9):1445-1455. doi: 10.2215/CJN.19891220. Epub 2021 Apr 15.